[ad_1] But in the latest batch of tests in September, only 44 out of 1,000 people tested positive for antibodies. “Immunity is declining quite fast, we are only three months away from our first test cycle and we are already showing a 26% drop in antibodies,” said Prof. Helen Ward, …
Read More »Results of the Phase 1 trial of the gorilla adenovirus vaccine for COVID-19
[ad_1] A recent study published on the prepress server bioRxiv* in October 2020 reports the development of a new vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help accelerate vaccine development. Low seroprevalence for simian adenoviruses Monkey adenoviruses are isolated …
Read More »